IP Library Granted Patent US 9,803,187
Granted Patent B2
US 9,803,187 · App. 14/717,096 · Granted Oct 31, 2017

Baulamycins, compositions and methods of use thereof

Inventors: David H. Sherman (Ann Arbor, MI); Ashootosh Tripathi (Ypsilanti, MI); Michael Marie Kaufman-Schofield (Ann Arbor, MI); Giselle Tamayo (Heredia, CR); Pam Schultz (Superior Township, MI)
Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN; ASOCIACION INSTITUTO NACIONAL DE BIODIVERSIDAD
C12N9/99C07C45/79C07C49/217C07C49/245C07C49/248C12N9/93A61K31/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,803,187
App. No.
14/717,096
Granted
Oct 31, 2017
Kind
B2
Abstract

Provided herein are compositions of compounds of formula (I), methods of inhibiting a bacterial infection by contacting a cell with a composition comprising a compound of formula (I), and methods of isolating compounds of formula (I) from an extract of Streptomyces tempisquensis.

Claims (10)

1. A method of inhibiting a nonribosomal peptide synthetase independent siderophore (NIS) synthetase comprising contacting the NIS synthetase with a composition comprising a pharmaceutically acceptable excipient and a compound of formula (I), or a pharmaceutically acceptable salt thereof,

wherein R 1 is a C 1-6 alkyl;

said composition contacted in an amount sufficient to inhibit the NIS synthetase.

2. The method of claim 1 , wherein the NIS synthetase is a Type A NIS synthetase.

3. The method of claim 1 , wherein the NIS synthetase is AsbA or SbnE.

4. The method of claim 1 , wherein the compound of formula (I), or pharmaceutically acceptable salt thereof, has a stereochemistry as shown in formula (IA):

5. The method of claim 1 , wherein the compound of formula (I) has a structure

or a pharmaceutically acceptable salt thereof.

6. The method of claim 1 , wherein the compound of formula (I) has a structure

or a pharmaceutically acceptable salt thereof.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jul 12, 2016
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039309/0140 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2016
From: TAMAYO, GISELLE
To: ASOCIACION INSTITUTO NACIONAL DE BIODIVERSIDAD
Reel/Frame 037810/0641 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2016
From: SHERMAN, DAVID H.; TRIPATHI, ASHOOTOSH; SCHOFIELD, MICHAEL M.; SCHULTZ, PAM
To: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Reel/Frame 037452/0597 →
Continuity (2)
Provisional Application 62000783 · May 20, 2014
Related Publication 20150337288A1 · Nov 26, 2015